MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease
Authors:
Open Access
- 26 January 2022
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 23 (3) , 1-10
Abstract
The aim of the present study was to investigate the expression levels of microRNA(miR)‑4722‑5p and miR‑615‑3p in Alzheimer's disease (AD) and their diagnostic value. Blood samples were collected from 33 patients with AD and 33 healthy controls, and an β‑amyloid (Aβ)25‑35‑induced PC12 cell model was also established. The relative mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were detected using reverse transcription‑quantitative PCR. The correlations between the mRNA expression levels of the two miRNAs and the mini‑mental state examination (MMSE) scores were analyzed, and the receiver operating characteristic curve was used to assess the diagnostic value of miR‑4722‑5p and miR‑615‑3p in AD. Functional enrichment analysis of the miRNA target genes was performed using The Database for Annotation, Visualization and Integrated Discovery database and the R language analysis package. The mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were increased in patients with AD and the Aβ25‑35‑induced PC12 cell model. The mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were negatively correlated with MMSE scores, and the combination of the two miRNAs for AD had an improved diagnostic value than that of each miRNA alone. The results of Gene Ontology (GO) enrichment analysis showed that the target genes of miR‑4722‑5p were found in the cytoplasm and cytosol, and were mainly involved in protein folding and cell division. The molecular functions included protein binding and GTPase activator activity. The results of Kyoto Encyclopedia of Genes and Genomes analysis showed that miR‑4722‑5p was associated with the regulation of dopaminergic synapses and mTOR signaling pathways. GO enrichment analysis also revealed that the target genes of miR‑615‑3p were located in the nucleus and cytoplasm, were involved in the regulation of transcription and protein phosphorylation, and were associated with protein binding, metal ion binding and transcription factor activity. The target genes of miR‑615‑3p played important roles in the regulation of the Ras and FoxO signaling pathways. In conclusion, miR‑4722‑5p and miR‑615‑3p may be potential biomarkers in the early diagnosis of AD.Keywords
This publication has 68 references indexed in Scilit:
- Specificity of miR-378a-5p targeting rodent fibronectinBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Targeting the mTOR Signaling Network for Alzheimer’s Disease TherapyMolecular Neurobiology, 2013
- Ushering in the study and treatment of preclinical Alzheimer diseaseNature Reviews Neurology, 2013
- A cAMP analog reverses contextual and tone memory deficits induced by a PKA inhibitor in Pavlovian fear conditioningPharmacology Biochemistry and Behavior, 2013
- Hyperbaric Oxygen and Ginkgo Biloba Extract Inhibit Aβ25-35-induced Toxicity and Oxidative Stress in vivo: A Potential Role in Alzheimer's DiseaseInternational Journal of Neuroscience, 2012
- Targeting the EGFR signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial DysfunctionThe Journal of Neuroscience, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975